Key result
During 13.1 months follow-up, atrial fibrillation recurred in 59.3% of patients, which was associated with older age (60.4 vs 55.3 years, P=0.022) and lower ACE-I/ARB use (27.0% vs 50.0%, P=0.025).
Why the study?
What are the clinical and serological predictors of failed electrical cardioversion and atrial fibrillation recurrence in patients with AF?
Cohort (n=81)
What are the clinical and serological predictors of failed electrical cardioversion and atrial fibrillation recurrence in patients with AF?
Older age, spontaneous echo contrast, under-utilization of RAAS inhibitors, and specific serological markers (high TGF-beta, low SDF-1alpha) predict failed cardioversion or AF recurrence.
No takes yet. Share an insight, caveat, or question.
Should not yet guide cardioversion decisions in AF; leaves open prospective validation of TGF-beta and SDF-1alpha.
Kim et al. (2009) conducted a cohort in Atrial fibrillation (n=81). Clinical, echocardiographic, and serological risk factors vs. Patients without these risk factors was evaluated on Failed electrical cardioversion and atrial fibrillation recurrence. During 13.1 months follow-up, atrial fibrillation recurred in 59.3% of patients, which was associated with older age (60.4 vs 55.3 years, P=0.022) and lower ACE-I/ARB use (27.0% vs 50.0%, P=0.025).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: